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Peptides can be displayed on the surface of t%mcntous bactcriophagcs by fusion to phagc coat proteins, It was recently shown that vast (IO”) 
collections of phages, each exposing a variant of the original peptide, can bc constructed and utilized as a general source of peptidc liyands. By 
panning these libraries on a target molecule linked to a solid support it is possible to select. out of the hundreds of millions of clones, those few 
phagcs that display a pcptide that binds the target molecule Searching these libraries is a powerful tool to be applied in many areas of fundamental 
and applied biology. 
Peptidc library; Filamentous phagc; Ligand binding 
1. INTRODUCTION 
The combination of protein over-expression technol- 
ogy and site-directed mutagenesis has allowed consider- 
able progress in the understanding of the relationship 
between amino acid sequence and protein conformation 
and function. Progress is limited, however, when the 
scarce understanding of the process of interest prompts 
researchers toformulate poor models that are not easily 
tested with the construction and characterization of a 
workable number of site-directed mutants. These prob- 
lems are better approached by selective methods involv- 
ing the simultaneous construction of a large collection 
of random mutants and the selection of those that are 
compatible with a given property. 
Recently a new general technology has been devel- 
oped that permits the application of a selective ap 
preach to the study of molecular recognition in pro- 
teins. Most importantly thistechnology does not rely on 
the recognition mechanism under investigation having 
a phenotype associated in common prokaryotic expres- 
sion organisms and can, in principle, be applied to 
eukaryotic or artificial peptides. 
2. PHAGE EXPOSITION TECHNOLOGY (PET) 
The method, which we call PET (Phage Exposition 
Technology) stems from the pioneering work of G. 
Correspo/r&ncc ad&~: G. Cesareni, Department of Biology, Univer- 
sity of Tor Vergata, Via Carnevalc, 00173 Rome, Italy. 
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Smith [l] and relies on the ability to display a peptide 
of interest on the surface of a bacteriophage capsid (Fig. 
1). The method begins with the fusing of a peptide (X), 
whose function under study is that of being able to bind 
a second molecule (Y), to a phage capsid protein. The 
fusion is engineered so that the foreign peptide does not 
affect phage capsid assembly and remains exposed to 
the solvent available for interaction with the target mol- 
ecule (Y). Usually the second step consists of the con- 
struction of a large collection of phage clones each syn- 
thesizing a different sequence variant of the fused pep- 
tide. The target molecule (Y) attached to a solid phase 
can then be used to separate, by standard chromato- 
graphic means, those phages presenting a protein X 
proficient in binding. The important point is that the 
physical inkage between protein X and its gene, medi- 
ated by the fusion to the coat protein, permits cloning 
and sequencing of the nucleotide sequence ncoding the 
peptide X variants that bind the ligate Y. The compar- 
ison of the predicted ammo acid sequences of the pep- 
tide X displayed on the selected clones is expected to 
reveal details of the recognition mechanism. Further- 
more PET can be used to select from such variant libra- 
ries novel binding properties that were not present in the 
original peptide. 
In principle other vectors can be used for studying 
protein-ligand interaction in a manner similar to what 
we have just described. For instance a variety of outer 
membrane proteins [24], or proteins that form the 
building block of bacterial thread-like organelles [5,6] 
are capable of presenting oligopeptides inserted into 
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Fig. I, Schematic representation rhybrid Rlamcntous phages displglng the X peptidc fused either to pII1 (left) or to pYlII &i&t). As described 
in more detail in the text, the display by fusion LO pVIll is achieved by yhenolypic mixing of a hybrid peptide X-pVIII fusion protein dispersed 
in a wild-type phage coat. The exact number of minor and major coat proteins is not known. 
specific regions of their structures in a form available 
for interaction with ligands present in the medium. Util- 
izing phages instead of bacteria, however, raises the 
number of clones that can be handled in a single exper- 
iment by a factor of lo3 and facilitates the construction 
and storage of large libraries. Furthermore bacterio- 
phages are simpler and more compact structures, and 
are therefore likely to have a smaller number of aspeci- 
fit interactions in the selective procedure. 
3. FILAMENTOUS PHAGE CAPSID 
In contrast to virulent bacteriophages that complete 
their life cycle by lysing the bacterial cell, filamentous 
phages do not kill their host. New pltage particles are 
secreted without breaking the integrity of the cell enve- 
lope. The secreted particles consist of a single molecule 
of circular single-strarlded DNA covered in a tubular 
array by approximately 2,700 copies of a small helical 
protein, the product of gene VIII (for a review see [7]). 
The virion structure has been studied in some detail by 
physical methods, and a model of the helical arrange- 
ment of the major coat proteins has been proposed [S]. 
The two ends of the viral filament are capped by two 
structures formed by four minor coat proteins that are 
present in 4-5 copies per phage particle; the products of 
gene VII and IX, on one side, and VI and III, on the 
other side (Fig. I). ~111, which emerges last from the 
infected bacterium, can be proteolytically split into two 
domains of similar dimensions [9]; the C-terminal do- 
main is necessary to stabilize the viral particle and to 
prevent he formation of polyheads while the N-terrni- 
nal domain binds to the phage receptor, the tip of F 
pilLt.5 in male bacteria. 
Smith and his collaborators have first shown that 
short peptides can be inserted close to the N-terminus 
of the pII1 protein without preventing its ability to as- 
semble and to recognize the bacterial receptor [1, IO, 1 I]. 
Furthermore the hybrid protein displays the foreign 
peptide in a form that can be recognized by a cognate 
antibody. The same authors have developed an efficient 
panning technique (Fig. 2j that permits selection of 
phage particles presenting a peptide that binds an anti- 
body molecule [ IO,1 21. This technique can be easily ex- 
tended, with minor modifications, to target molecules 
that are different from antibodies. An important char- 
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Fig. 2. Selection from an epitope library of a filamentous phage that displays a pcptide that binds a Fab fragment of immunoglobulin. The Fab 
fragment is linked to a plastic Petri dish via a biatin-streptavidin bridge. The sclcction technique, known as biopanning, is described in detail by 
Scott and Smith [I31 
acteristic of filamentous phages is their ability to survive 
exposure to extreme conditions (9X, pH 2) thereby 
allowing recovery of tile bound phages by breakage of 
the non-covalent bonds between displayed and target 
molecules without eliminating phagc infectivity. 
Although only a limited number of experiments have 
been published, evidence is accumulating that PET is 
rather general and is subjected to few if any limitations. 
Most likely any peptide that can be passively translo- 
cated across a membrane, once fused to the N-terminus 
of mature pII protein, will be displayed on the phage 
capsid. It is conceivable, however, that some of these 
N-terminal extensions will decrease or abolish phage 
infectivity [lo]. Even in these cases, Izowever, phage 
infectivity can be preserved by constructing hybrid 
phage particles where most pIII copies are wild-type 
while only one or a few are hybrid pII1 carrying the 
N-terminal extension [13]. This is achieved by pheno- 
typic mixing of the hybrid plII synthesized by a gene 
carried on a plasmid and the wild-type gene III product 
synthesized by a superinfecting phage. If the resident 
plasmid contains the filamentous phage replication ori- 
gin (plzagemid), the supernatant of the bacterial culture 
will contain phage and phagemid particles that are both 
infective and display the peptide fused to ~111, as en- 
coded in the phagemid gene. A further advantage of the 
phagemid system is the ability to decrease tlle number 
of copies of pcptides displayed down to fewer tlzan 1 
copy per phage particle. This means that each phage is 
monovalent with respect o binding to the target mole- 
cule, thus eliminating possible avidity effects during the 
enrichment procedure. 
A second displayed method, also based on filamcn- 
tous phages, was developed more recently. It relies on 
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the ability to incorporate short peptides on phage 
capsids by fusion to the N-terminus of gene VIII protein 
[14-163. In contrast o the 4-S copies that constitute the 
maximum number of peptides that can be presented on 
a single phage particle by fusion to pIII, the utilization 
of pVII1 as a carrier permits to cover a phage with up 
to approximately 2,700 peptides. In practice, however, 
it has been observed that hybrid pVII1 prot,eins cx- 
tended at the N-terminus with peptides that are longer 
than six amino acids do not form viable phage particles 
[ 15,163. This is probably due to some interference be- 
tween the closely packed N-terminally extended sub- 
units. As a consequence, for most applications, it be- 
comes vita! to use a phagemid vector carrying the mod- 
ified gene VIII. By superinfection wit!1 a wild-type 
helper phage it is then possible to assemble hybrid 
capsids where the mutated protein VIII is dispersed in 
an otllerwise wild-type capsid. Peptides as small as six 
amino acids [15] or as long as an entire Fab fragment 
[17] have been successfully linked to phage capsids by 
this method. A survey of peptides of 9 amino acids of 
random sequence has indicated that at least 80% of 
tllem can be successfully translocated across the mem- 
brane and presented on phage capsids when inserted 
after the fifth amino acid of the mature pVII1 (our 
unpublished results). The density of the peptide on the 
phage surface depends somewhat on the peptidc se- 
quence and varies between 1 ,OOO/phage (approximately 
l/3 of the total number major capsid protein subunits) 
and less than lOO/phage. By controlling the activity of 
the promoter (pLac) in front of gene VIII on the plas- 
mid, it is also possible to modulate, within a factor of 
ten, the density of a given peptide (our unpublished 
resuhsj. 
Volume 307, number I FEBS LETTERS July 1992 
4. OLIGOPEPTIDE LIBRARIES 
The first demonstration of the power of the PET 
technology came from model experiments hat used an- 
tibodies as ligate molecule to select ligands from large 
‘epitope’ libraries made of lo’-10” hybrid phages each 
displaying an oligopeptide of different sequence. 
Scott and Smith [I l] constructed a library of 200 
million different hexapeptides inserted after the first 
four amino acids at the N-terminus of mature ~111. A 
subset of this library was used to demonstrate that the 
biopanning technique is sufficiently sensitive and selec- 
tive to recover, from this random collection of peptides, 
those that bind two monoclonal antibodies raised 
against he hexapeptide, DFLEKI. 
In an analogous experiment Dower’s group [I81 con- 
structed a 300 million hexapeptide library, in which the 
variable region begins at the N-terminus of mature ~111. 
A monoclonal antibody that binds tightly to the N- 
terminus of /3-endorphin (YGGF) was used to select 
phage clones that present peptide ligands on the capsid. 
As in the previous experiment [I 11, the majority of the 
50 clones that were characterized bore a resemblance to
the peptide that was used to raise the antibody. 
Our group [16] used a phagemid system to assemble 
a library of 37 million clones each presenting a nona- 
peptide of random sequence inserted after the fifth 
amino acid of mature pVII1. Phagemid clones that bind 
a monoclonal antibody raised against oligopeptide l63- 
171 of interleukin 1s were selected and the displayed 
peptide determined by DNA sequencing. The selected 
peptides all contain the consensus SND/E that is also 
present in the ILIp nonapeptide that was used to raise 
the antibody, thus defining the SND region as a critical 
region for MAb recognition. 
The recovery, in the three different panning experi- 
ments, of peptides that resemble the original antigen 
demonstrates that the biopanning technique preferen- 
tially selects peptide clones that bind the ‘antigen bind- 
ing site’ with atomic contacts that are similar to those 
of the natural epitope. Whatever its molecular explana- 
tion, this finding renders epitope mapping possible since 
one can expect to identify an unknown immunogenic 
epitope by exploiting the consensus, determined from 
the selected peptides, as a searching template. Stephen 
and Lane [IP] used an hexapeptide library to identify an 
epitope that is unmasked by a conformational change 
that occurs in some p53 mutants. 
Epitope libraries have also been successfully used to 
search for peptide ligands that mimic non-proteinous 
ligands. Devlin’s group selected, from a decapentapep- 
tide library on ~111, peptides that mimic biotin binding 
to streptavidin identifying the consensus tripeptide 
HPQ. Phages bearing the consensus peptide, YPY, were 
selected by two different groups from an exapeptide and 
an octapeptide library using the plant lectin, concana- 
valin A (Con A), as a ligate [20,21]. This tripeptide 
(YPY) was found to be highly selective for Con A since 
phages exposing these peptides do not bind to closely 
related pea or lentil lectins. 
Although we are still in the beginning of the develop- 
ment and exploitation of the PET technology, there is 
expectation that, with the construction of slightly more 
complex and sophisticated libraries (larger size, con- 
strained peptides, mixtures of peptide libraries in differ- 
ent structural contexts, etc.), the method could be pner- 
ally used to find !igands for practically any target mole- 
cule. It is not difficult to imagine the possible applica- 
tions of this type of approach to the development of 
vaccines or diagnostics and to the discovery of ligands 
for targets of medical interest. The structural informa- 
tion extracted from the consensus, derived from the 
selected peptides, could then be used to develop non- 
peptide drugs of therapeutic interest. 
5. DISPLAY OF PROTEINS OR PROTEIN DO- 
MAINS 
The applications of PET technology are not limited 
to the display of libraries of small peptides of random 
sequence. Although it has been shown that some pep- 
tides of larger sizes (approx. 100 amino acids) may pre- 
vent phage propagation by interfering with the receptor 
recognition function of pII1 [IO], the development of 
phagemid vectors that permit the assembly of singIe 
hybrid pII1 protein on otherwise wild-type phage 
capsids (monovalent display), has removed this limita- 
tion. Wells and collaborators have used ,filamentous 
phages that display the human growth hormone [13] to 
select mutants that bind to the cognate receptor with an 
affinity higher than that of the natural hormone [22]. A 
similar approach was exploited by Roberts et al. [23] to 
change the specificity of a protease inhibitor, thereby 
selecting a molecule that is 50-times more potent in 
inhibiting human neutrophil elastase (HNE) than any 
other anti-HNE Kunitz derivative described. Other 
large peptides that have been successfully displayed in 
the native conformation are the enzyme, alkaline phos- 
phatase [24], and an immunogenic fragment of the HIV 
Gag protein [25]. 
Perhaps the most impressive application of the tech- 
nology originates from the demonstration that variable 
fragments of immunoglobulins (either Fab or Fv) can 
be displayed on phage capsids (phagebodies) [ 17,26-3 11. 
Combined with the ability to clone, by PCR amplifica- 
tion, large libraries of heavy and light chain immuno- 
globulin genes, this permits the enrichment of those 
phagebodies that bind to any ligate molecule, bypassing 
both hybridoma technology and immunization. Re- 
cently, Winter and co-workers have shown that a single 
large phage library, displaying different combinations 
of heavy and light chain fragments from a non-immu- 
nized individual, can be used to isolate human antibod- 
ies against any antigen [32]. 
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6. CONCLUSIONS 
A discussion of future developments and applications 
risks to be superseded by the experiments hat are now 
carried out in various laboratories will probably be pub- 
lished by the time this review goes to press. Applications 
are only limited by the ingenuity of scientists and are not 
confined to the study of peptide-ligand interaction. 
PET technology essentially permits the link between the 
ability of a peptide to reach the phage capsid and asLo- 
ciate and dissociate from a ligand to the phage replica- 
tion and amplification properties. Any phenomenon 
that may interfere with the assembly-association-disso- 
ciation process can be studied by this technology. 
Among these are peptide secretion, protein folding and 
stability, and formation of covalent bonds during an 
enzymatic reaction. 
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